Surgical management of National Institutes of Health category II chronic bacterial prostatitis: a case series and scoping review of the literature.

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-142/coif). DS serves as an unpaid editorial board member of Translational Andrology and Urology from August 2022 to July 2024. SDL reports that he received a grant from the American Urological Association. DS reports receiving payment for the American Urological Association Board Review course. He is paid for 5 lectures, all unrelated to the subject of this paper. He reports patents planned but unrelated to this work. He reports roles on several boards which are all medical non-profits and unpaid positions. Finally, he reports stock or stock options with Triural licenses nutraceuticals for category III prostatitis. He is also currently a full-time employee of Pacific Edge Diagnostics whose products in bladder cancer are completely unrelated to the subject of this paper. The other authors have no conflicts of interest to declare."

"Funding: None."